Research

Hormonal

Combined pharmacological administration of oxytocin (OT) and a selective CCKAR agonist (A-71263) produces greater weight loss and fat mass reduction than either agent alone in diet-induced obese mice.

Combining oxytocin with a CCK receptor agonist is more effective for weight loss than using either drug alone. This suggests that future obesity treatments might need to target multiple pathways simultaneously to overcome diet-induced resistance.

GoodSupportsHIGH confidence
Combined OTR-CCKAR co-agonism improves metabolic outcomes in DIO mice
Tim Gruber et al. · Cell Reports · 2023

Why this rating

Strong mechanistic evidence using polypharmacology in mouse models.

Source

High-calorie diets uncouple hypothalamic oxytocin neurons from a gut-to-brain satiation pathway via κ-opioid signaling

Tim Gruber et al. · Cell Reports · 2023

DOI 10.1016/j.celrep.2023.113305

mechanism_onlyCited 23×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →